Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Haffner

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Nature Communications|July 28, 2017
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationMichael C Haffner, David M Esopi, Alcides Chaux, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Cancer Discovery|January 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA MethylationGian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
Nature Methods|June 22, 2026
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Genome Biology|December 15, 2020
Convergent network effects along the axis of gene expression during prostate cancer progressionKonstantina Charmpi, Tiannan Guo, Qing Zhong, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Nature Communications|July 28, 2017
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationMichael C Haffner, David M Esopi, Alcides Chaux, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Cancer Discovery|January 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA MethylationGian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
Nature Methods|June 22, 2026
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Genome Biology|December 15, 2020
Convergent network effects along the axis of gene expression during prostate cancer progressionKonstantina Charmpi, Tiannan Guo, Qing Zhong, et al.
Pageof 17